{"database": "lobbying", "table": "lobbying_activities", "rows": [[2461094, "78a190db-be16-4e1f-b5ee-6abd8a3d76a7", "Q2", "EAST END GROUP, LLC", 400646949, "RIDGEBACK BIOTHERAPEUTICS", 2020, "second_quarter", "HCR", "Legislative and regulatory issues related to pandemic and emerging infectious disease preparedness and response.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2020-07-03T12:37:41.920000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2461094"], "units": {}, "query_ms": 0.46339898835867643, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}